Certain New Chemicals or Significant New Uses; Statements of Findings for May 2021, 37325-37326 [2021-15086]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 133 / Thursday, July 15, 2021 / Notices
Respiratory Syndrome Coronavirus 2
(SARS–CoV–2), the causal agent of
COVID–19. The use is effective January
19, 2021 to August 24, 2021.
California
Department of Pesticide Regulation
Specific exemption: EPA authorized
the use of kasugamycin on a maximum
of 100,000 acres of almond trees to
control bacterial blast (Pseudomonas
syringae pv. syringae). A time-limited
tolerance in connection with a past
action has been established in 40 CFR
180.614(b). Effective February 11, 2021
to April 15, 2021.
Florida
Department of Agriculture and
Consumer Services
Specific exemptions: EPA authorized
the use of streptomycin on up to
330,254 acres of citrus to manage citrus
greening disease (also known as
Huanglongbing). Time-limited
tolerances in connection with past
actions for this use have been
established in 40 CFR 180.245(b).
Effective December 31, 2020 to
December 31, 2021.
EPA authorized the use of the
insecticide clothianidin on a maximum
of 125,376 acres of immature (3 to 5
years old) citrus trees to control the
Asian citrus psyllid, the vector of citrus
greening disease (also known as
Huanglongbing) to manage disease
transmission. A time-limited tolerance
in connection with this action has been
established in 40 CFR 180.586(b);
Effective January 1, 2021 to October 31,
2021.
Georgia
Department of Agriculture
khammond on DSKJM1Z7X2PROD with NOTICES
Public health exemption: EPA
authorized the use of triethylene glycol
as an indoor air treatment at various
sites in Georgia when adherence to
current public health guidelines is
impractical, difficult to maintain, or is
not expected to provide a sufficient
level of protection, to control the Severe
Acute Respiratory Syndrome
Coronavirus 2 (SARS–CoV–2), the
causal agent of COVID–19. The use is
effective January 14, 2021 to January 14,
2022.
Louisiana
Department of Agriculture and Forestry
Specific exemption: EPA authorized
the use of triclopyr on a maximum of
450,000 acres of sugarcane to control
divine nightshade. A time-limited
tolerance in connection with this action
has been established in 40 CFR
VerDate Sep<11>2014
17:11 Jul 14, 2021
Jkt 253001
180.417(b); Effective October 2, 2020 to
May 31, 2021.
Massachusetts
Department of Agriculture and
Resources
Specific exemption: EPA authorized
the use of pronamide on a maximum of
5,000 acres of cranberries to control
dodder. A time-limited tolerance in
connection with this action has been
established in 40 CFR 180.679(b).
Effective April 15, 2021 to June 30,
2021.
Department of Agriculture
Public health exemption: EPA
authorized the use of 1octadecanaminium, N,N-dimethyl-N-[3(trihydroxysilyl)propyl] chloride on
non-porous, non-food-contact surfaces
in American Airlines aircraft and airport
facilities to control the Severe Acute
Respiratory Syndrome Coronavirus 2
(SARS–CoV–2), the causal agent of
COVID–19. The use is effective January
19, 2021 to August 24, 2021.
Tennessee
Department of Agriculture
Public health exemption: EPA
authorized the use of triethylene glycol
as an indoor air treatment at various
sites in Tennessee when adherence to
current public health guidelines is
impractical, difficult to maintain, or is
not expected to provide a sufficient
level of protection, to control the Severe
Acute Respiratory Syndrome
Coronavirus 2 (SARS–CoV–2), the
causal agent of COVID–19. The use is
effective January 14, 2021 to January 14,
2022.
B. Federal Departments and Agencies
Agriculture Department
Animal and Plant Health Inspector
Service
Quarantine Exemption: EPA
authorized the use of acetic acid on
nonporous surfaces to decontaminate
from foot and mouth disease virus;
Effective April 19, 2021 to April 19,
2024.
National Aeronautics and Space
Administration
Specific exemption: EPA authorized
use of ortho-phthalaldehyde,
immobilized to a porous resin, to treat
the International Space Station (ISS)
internal active thermal control system
(IATCS) coolant for control of aerobic
and microaerophilic water bacteria and
unidentified gram-negative rods.
Effective October 9, 2020 to October 9,
Frm 00052
2021. This request was granted because
without this use, the ISS would have no
means of controlling microorganisms in
the IATCS because there are no
registered alternatives available which
meet the required criteria. Since this
request proposed a use of a new
(unregistered) chemical, in accordance
with the requirements at 40 CFR 166.24,
a notice of receipt published in the
Federal Register on September 25, 2020
(85 FR 60458) (FRL–10014–21) with the
public comment period closing on
October 13, 2020.
Authority: 7 U.S.C. 136 et seq.
Oklahoma
PO 00000
37325
Fmt 4703
Sfmt 4703
Dated: July 9, 2021.
Marietta Echeverria,
Acting Director, Registration Division, Office
of Pesticide Programs.
[FR Doc. 2021–15043 Filed 7–14–21; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OPPT–2021–0146; FRL–8682–01–
OCSPP]
Certain New Chemicals or Significant
New Uses; Statements of Findings for
May 2021
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
The Toxic Substances Control
Act (TSCA) requires EPA to publish in
the Federal Register a statement of its
findings after its review of certain TSCA
notices when EPA makes a finding that
a new chemical substance or significant
new use is not likely to present an
unreasonable risk of injury to health or
the environment. Such statements apply
to premanufacture notices (PMNs),
microbial commercial activity notices
(MCANs), and significant new use
notices (SNUNs) submitted to EPA
under TSCA. This document presents
statements of findings made by EPA on
such submissions during the period
from May 1, 2021 to May 31, 2021.
FOR FURTHER INFORMATION CONTACT:
For technical information contact:
Rebecca Edelstein, New Chemical
Division (7405M), Office of Pollution
Prevention and Toxics, Environmental
Protection Agency, 1200 Pennsylvania
Ave. NW, Washington, DC 20460–0001;
telephone number: 202–564–1667 email
address: Edelstein.rebecca@epa.gov.
For general information contact: The
TSCA-Hotline, ABVI-Goodwill, 422
South Clinton Ave., Rochester, NY
14620; telephone number: (202) 554–
1404; email address: TSCA-Hotline@
epa.gov.
SUMMARY:
E:\FR\FM\15JYN1.SGM
15JYN1
37326
Federal Register / Vol. 86, No. 133 / Thursday, July 15, 2021 / Notices
during the period from May 1, 2021 to
May 31, 2021.
SUPPLEMENTARY INFORMATION:
I. General Information
III. What is the Agency’s authority for
taking this action?
A. Does this action apply to me?
This action is directed to the public
in general. As such, the Agency has not
attempted to describe the specific
entities that this action may apply to.
Although others may be affected, this
action applies directly to the submitters
of the PMNs addressed in this action.
khammond on DSKJM1Z7X2PROD with NOTICES
TSCA section 5(a)(3) requires EPA to
review a TSCA section 5(a) notice and
make one of the following specific
findings:
• The chemical substance or
significant new use presents an
unreasonable risk of injury to health or
the environment;
B. How can I get copies of this document
• The information available to EPA is
and other related information?
insufficient to permit a reasoned
evaluation of the health and
The docket for this action, identified
environmental effects of the chemical
by docket identification (ID) number
EPA–HQ–OPPT–2021–0146, is available substance or significant new use;
• The information available to EPA is
online at https://www.regulations.gov or
insufficient to permit a reasoned
in-person at the Office of Pollution
evaluation of the health and
Prevention and Toxics Docket (OPPT
environmental effects and the chemical
Docket), Environmental Protection
substance or significant new use may
Agency Docket Center (EPA/DC), West
present an unreasonable risk of injury to
William Jefferson Clinton Bldg., Rm.
health or the environment;
3334, 1301 Constitution Ave. NW,
• The chemical substance is or will
Washington, DC. The Public Reading
be produced in substantial quantities,
Room is open from 8:30 a.m. to 4:30
p.m., Monday through Friday, excluding and such substance either enters or may
reasonably be anticipated to enter the
legal holidays. The telephone number
environment in substantial quantities or
for the Public Reading Room is (202)
566–1744, and the telephone number for there is or may be significant or
substantial human exposure to the
the OPPT Docket is (202) 566–0280.
substance; or
Due to the public health concerns
• The chemical substance or
related to COVID–19, the EPA Docket
significant new use is not likely to
Center (EPA/DC) and Reading Room is
present an unreasonable risk of injury to
closed to visitors with limited
health or the environment.
exceptions. The staff continues to
Unreasonable risk findings must be
provide remote customer service via
made without consideration of costs or
email, phone, and webform. For the
other non-risk factors, including an
latest status information on EPA/DC
unreasonable risk to a potentially
services and docket access, visit https:// exposed or susceptible subpopulation
www.epa.gov/dockets.
identified as relevant under the
conditions of use. The term ‘‘conditions
II. What action is the Agency taking?
of use’’ is defined in TSCA section 3 to
This document lists the statements of
mean ‘‘the circumstances, as determined
findings made by EPA after review of
by the Administrator, under which a
notices submitted under TSCA section
chemical substance is intended, known,
5(a) that certain new chemical
or reasonably foreseen to be
substances or significant new uses are
manufactured, processed, distributed in
not likely to present an unreasonable
commerce, used, or disposed of.’’
EPA is required under TSCA section
risk of injury to health or the
5(g) to publish in the Federal Register
environment. This document presents
a statement of its findings after its
statements of findings made by EPA
EPA case No.
Chemical identity
J–21–0010 ...................
Genetically modified microorganism for the production of a chemical
substance (Generic Name).
Authority: 15 U.S.C. 2601 et seq.
review of a TSCA section 5(a) notice
when EPA makes a finding that a new
chemical substance or significant new
use is not likely to present an
unreasonable risk of injury to health or
the environment. Such statements apply
to PMNs, MCANs, and SNUNs
submitted to EPA under TSCA section
5.
Anyone who plans to manufacture
(which includes import) a new chemical
substance for a non-exempt commercial
purpose and any manufacturer or
processor wishing to engage in a use of
a chemical substance designated by EPA
as a significant new use must submit a
notice to EPA at least 90 days before
commencing manufacture of the new
chemical substance or before engaging
in the significant new use.
The submitter of a notice to EPA for
which EPA has made a finding of ‘‘not
likely to present an unreasonable risk of
injury to health or the environment’’
may commence manufacture of the
chemical substance or manufacture or
processing for the significant new use
notwithstanding any remaining portion
of the applicable review period.
IV. Statements of Administrator
Findings Under TSCA Section 5(a)(3)(C)
In this unit, EPA provides the
following information (to the extent that
such information is not claimed as
Confidential Business Information
(CBI)) on the PMNs, MCANs and
SNUNs for which, during this period,
EPA has made findings under TSCA
section 5(a)(3)(C) that the new chemical
substances or significant new uses are
not likely to present an unreasonable
risk of injury to health or the
environment:
• EPA case number assigned to the
TSCA section 5(a) notice.
• Chemical identity (generic name if
the specific name is claimed as CBI).
• Website link to EPA’s decision
document describing the basis of the
‘‘not likely to present an unreasonable
risk’’ finding made by EPA under TSCA
section 5(a)(3)(C).
Website link
https://www.epa.gov/reviewing-new-chemicals-under-toxic-substances-control-act-tsca/tsca-section-5a3c-determination-509.
Dated: July 7, 2021.
Madison Le,
Director, New Chemicals Division, Office of
Pollution Prevention and Toxics.
[FR Doc. 2021–15086 Filed 7–14–21; 8:45 am]
BILLING CODE 6560–50–P
VerDate Sep<11>2014
17:11 Jul 14, 2021
Jkt 253001
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
E:\FR\FM\15JYN1.SGM
15JYN1
]]>Agencies
[Federal Register Volume 86, Number 133 (Thursday, July 15, 2021)]
[Notices]
[Pages 37325-37326]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15086]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPPT-2021-0146; FRL-8682-01-OCSPP]
Certain New Chemicals or Significant New Uses; Statements of
Findings for May 2021
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Toxic Substances Control Act (TSCA) requires EPA to
publish in the Federal Register a statement of its findings after its
review of certain TSCA notices when EPA makes a finding that a new
chemical substance or significant new use is not likely to present an
unreasonable risk of injury to health or the environment. Such
statements apply to premanufacture notices (PMNs), microbial commercial
activity notices (MCANs), and significant new use notices (SNUNs)
submitted to EPA under TSCA. This document presents statements of
findings made by EPA on such submissions during the period from May 1,
2021 to May 31, 2021.
FOR FURTHER INFORMATION CONTACT:
For technical information contact: Rebecca Edelstein, New Chemical
Division (7405M), Office of Pollution Prevention and Toxics,
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington,
DC 20460-0001; telephone number: 202-564-1667 email address:
[email protected].
For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address: [email protected].
[[Page 37326]]
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public in general. As such, the
Agency has not attempted to describe the specific entities that this
action may apply to. Although others may be affected, this action
applies directly to the submitters of the PMNs addressed in this
action.
B. How can I get copies of this document and other related information?
The docket for this action, identified by docket identification
(ID) number EPA-HQ-OPPT-2021-0146, is available online at https://www.regulations.gov or in-person at the Office of Pollution Prevention
and Toxics Docket (OPPT Docket), Environmental Protection Agency Docket
Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC. The Public Reading Room is open
from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal
holidays. The telephone number for the Public Reading Room is (202)
566-1744, and the telephone number for the OPPT Docket is (202) 566-
0280.
Due to the public health concerns related to COVID-19, the EPA
Docket Center (EPA/DC) and Reading Room is closed to visitors with
limited exceptions. The staff continues to provide remote customer
service via email, phone, and webform. For the latest status
information on EPA/DC services and docket access, visit https://www.epa.gov/dockets.
II. What action is the Agency taking?
This document lists the statements of findings made by EPA after
review of notices submitted under TSCA section 5(a) that certain new
chemical substances or significant new uses are not likely to present
an unreasonable risk of injury to health or the environment. This
document presents statements of findings made by EPA during the period
from May 1, 2021 to May 31, 2021.
III. What is the Agency's authority for taking this action?
TSCA section 5(a)(3) requires EPA to review a TSCA section 5(a)
notice and make one of the following specific findings:
The chemical substance or significant new use presents an
unreasonable risk of injury to health or the environment;
The information available to EPA is insufficient to permit
a reasoned evaluation of the health and environmental effects of the
chemical substance or significant new use;
The information available to EPA is insufficient to permit
a reasoned evaluation of the health and environmental effects and the
chemical substance or significant new use may present an unreasonable
risk of injury to health or the environment;
The chemical substance is or will be produced in
substantial quantities, and such substance either enters or may
reasonably be anticipated to enter the environment in substantial
quantities or there is or may be significant or substantial human
exposure to the substance; or
The chemical substance or significant new use is not
likely to present an unreasonable risk of injury to health or the
environment.
Unreasonable risk findings must be made without consideration of
costs or other non-risk factors, including an unreasonable risk to a
potentially exposed or susceptible subpopulation identified as relevant
under the conditions of use. The term ``conditions of use'' is defined
in TSCA section 3 to mean ``the circumstances, as determined by the
Administrator, under which a chemical substance is intended, known, or
reasonably foreseen to be manufactured, processed, distributed in
commerce, used, or disposed of.''
EPA is required under TSCA section 5(g) to publish in the Federal
Register a statement of its findings after its review of a TSCA section
5(a) notice when EPA makes a finding that a new chemical substance or
significant new use is not likely to present an unreasonable risk of
injury to health or the environment. Such statements apply to PMNs,
MCANs, and SNUNs submitted to EPA under TSCA section 5.
Anyone who plans to manufacture (which includes import) a new
chemical substance for a non-exempt commercial purpose and any
manufacturer or processor wishing to engage in a use of a chemical
substance designated by EPA as a significant new use must submit a
notice to EPA at least 90 days before commencing manufacture of the new
chemical substance or before engaging in the significant new use.
The submitter of a notice to EPA for which EPA has made a finding
of ``not likely to present an unreasonable risk of injury to health or
the environment'' may commence manufacture of the chemical substance or
manufacture or processing for the significant new use notwithstanding
any remaining portion of the applicable review period.
IV. Statements of Administrator Findings Under TSCA Section 5(a)(3)(C)
In this unit, EPA provides the following information (to the extent
that such information is not claimed as Confidential Business
Information (CBI)) on the PMNs, MCANs and SNUNs for which, during this
period, EPA has made findings under TSCA section 5(a)(3)(C) that the
new chemical substances or significant new uses are not likely to
present an unreasonable risk of injury to health or the environment:
EPA case number assigned to the TSCA section 5(a) notice.
Chemical identity (generic name if the specific name is
claimed as CBI).
Website link to EPA's decision document describing the
basis of the ``not likely to present an unreasonable risk'' finding
made by EPA under TSCA section 5(a)(3)(C).
------------------------------------------------------------------------
EPA case No. Chemical identity Website link
------------------------------------------------------------------------
J-21-0010....................... Genetically https://
modified www.epa.gov/
microorganism for reviewing-new-
the production of chemicals-under-
a chemical toxic-substances-
substance control-act-tsca/
(Generic Name). tsca-section-5a3c-
determination-
509.
------------------------------------------------------------------------
Authority: 15 U.S.C. 2601 et seq.
Dated: July 7, 2021.
Madison Le,
Director, New Chemicals Division, Office of Pollution Prevention and
Toxics.
[FR Doc. 2021-15086 Filed 7-14-21; 8:45 am]
BILLING CODE 6560-50-P
